EYPTEyePoint Pharmaceuticals, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $13.11 (-2.16% today)

Market Cap: $1.12B

P/E (TTM): -4.80

Analyst Upside: 186.0%

Relative Strength (RS%): 7

-31.4% from 52-week high

Back to Scanner

EYPT

NASDAQRS 7Score 16

EyePoint Pharmaceuticals, Inc.

HealthcareBiotechnology$1.12B1 setup passing
$13.11
-2.2% ($0.29)
-31.4% from 52W High
P/E (TTM)
-4.80
Fwd P/E
PEG
Analyst Upside
+186.0%
EPS Growth
Gross Margin
93.4%
ROE
-88.3%
D/E
0.07
Div Yield
0.0%
Avg Volume
1.2M

Price Chart

Key Levels

SMA 200
$13.33
SMA 50
$14.53
Price
$13.11
52W High
$19.11
Target
$37.50

Setup Radar

1/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst